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Abstract
Background: In vitro labelling of cells and small cell structures is a necessary step before in vivo monitoring of grafts.
We modified and optimised a procedure for pancreatic islet labelling using bimodal positively charged poly(lactic-co-
glycolic acid) nanoparticles with encapsulated perfluoro crown ethers and indocyanine green dye via microporation
and compared the method with passive endocytosis.
Results: Pancreatic islets were microporated using two pulses at various voltages. We tested a standard procedure
(poration in the presence of nanoparticles) and a modified protocol (pre-microporation in a buffer only, and subsequent
islet incubation with nanoparticles on ice for 10 min).
We compared islet labelling by microporation with labelling by endocytosis, i.e. pancreatic islets were incubated for 24 h
in a medium with suspended nanoparticles.
In order to verify the efficiency of the labelling procedures, we used 19F magnetic resonance imaging, optical
fluorescence imaging and confocal microscopy.
The experiment confirmed that microporation, albeit fast and effective, is invasive and may cause substantial harm to
islets. To achieve sufficient poration and to minimise the reduction of viability, the electric field should be set at 20 kV/m
(two pulses, 20 ms each).
Poration in the presence of nanoparticles was found to be unsuitable for the nanoparticles used. The water suspension of
nanoparticles (which served as a surfactant) was slightly foamy and microbubbles in the suspension were responsible for
sparks causing the destruction of islets during poration. However, pre-microporation (poration of islets in a buffer only)
followed by 10-min incubation with nanoparticles was safer.
Conclusions: For labelling of pancreatic islets using poly(lactic-co-glycolic acid) nanoparticles, the modified microporation
procedure with low voltage was found to be safer than the standard microporation procedure. The modified procedure
was fast, however, efficiency was lower compared to endocytosis.
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Background
Organ transplantations are widely used as therapeutic pro-
cedures for various diseases. However, due to limited
organ availability, immunological problems and substan-
tial organ impairment during surgery or cold ischemia,
cell transplantations have now become a focus of biomed-
ical research [1]. In several areas, such as the transplant-
ation of haematopoietic stem cells [2] and pancreatic islets
[3, 4], procedures have been established in clinical practice
to treat both leukaemia and Type 1 diabetes mellitus, re-
spectively. Nevertheless, cell (or small tissue structure)
transplantations are, even after 20 years of research, still at
a developmental stage and further research tools are re-
quired in order to monitor transplantation outcomes. Of
the various in vivo imaging methods for imaging trans-
planted cells, most require cells and cell structures to be
suitably labelled [5].
Labels may bear the following: a radionuclide for positron
emission tomography (PET) and single-photon emission
computed tomography (SPECT); a fluorescent dye for op-
tical imaging; a paramagnetic or superparamagnetic core
for 1H magnetic resonance imaging (MRI); a fluorine com-
pound for 19F MRI. Labels and detection methods differ
with regard to the sensitivity, specificity and accuracy of
spatial localisation. Sensitive PET and SPECT lack sufficient
spatial resolution [6], 1H MRI at high spatial resolution is
not specific [7], specific 19F MRI lacks sensitivity [8] and
the sensitivity of optical imaging substantially decreases
with distance from the surface [9]. Therefore, in order to
take advantage of several imaging methods, bi- or multi-
modal labels are often used [5].
Cell labelling using 19F tracers was reported for the first
time by Ahrens et al. [10]. Various labels containing fluori-
nated compounds have been successfully used for in vitro la-
belling and in vivo tracking of stem cells [11, 12] or immune
cells [13, 14], and were even used in vivo for human mono-
nuclear cells [15] in an animal model. Moreover, 19F tracers
can be used for quantification of cells in vivo [13, 16]. In
addition, combination of two types of labels may be advanta-
geous for monitoring of two distinct cell populations or their
interaction [17].
Various labelling procedures are used for different im-
aging modalities [18]: simple endocytosis [7], enhanced
endocytosis using a suitable transfection agent [19], la-
belling using a specific antigen [20] and electro- or
micro-poration [21]. Similar procedures used for cell la-
belling can be adapted for labelling pancreatic islets (PIs)
[22] and imaging strategies can be combined [23]. In
addition to the most common labelling procedure which
uses endocytosed iron oxide nanoparticles, particles can
be bound to islet surfaces [24] or gadolinium-based
paramagnetic labels can be used [25]. The influence of
positively charged nanoparticles upon uptake has also
been reported [26].
Microporation (electroporation in a capilary using a
higher voltage) was introduced by Kim et al. [27] and
Lim et al. [28] although they used the method for gene
delivery into the cells. Electroporation for labelling of
PIs was used for the first time by Foster et al. [29].
Labelling pancreatic islets is particularly difficult due to
their structure [30, 31]. Highly vascularized organs consist
of endocrine cells secreteing insuline (β-cells), glucagon
(α-cells), somatostatin (δ-cells), pancreatic-polypeptide
(PP-cells), and ghrelin (ε-cells). The structure differs
among species; for example, rodent islets broadly used in
experiments have defined β-cell core surrounded by α-
cells and other endocrine cells in the periphery. Human
islets have endocrine cells more scattered (with higher
number of α-cells). Different architecture influences islet
function and its sensitivity to low glucose concentrations.
Labelling procedures therefore may affect different cells in
the case of animal and human islets, which should be kept
in mind when translating the experiments to clinical prac-
tice. To avoid usage of transfection agents and to keep the
labelling system simple, a positive charge added to the
label surface may increase cell labelling efficiency [26].
Although electroporation was used for pancreatic islet
labelling by nanoparticles [32], microporation described
by Kim et al. [27] is used mostly for gene delivery into
stem cells [28] or into pancreatic islets [33], or for label-
ling of islets by small molecules [34].
In this study, we optimised the parameters of a micro-
poration procedure for labelling rat PIs using positive-
charged bimodal nanoparticles for 19F MRI and optical
imaging. The procedure was modified to improve label-
ling outcomes in comparison with endocytic labelling.
Methods
Nanoparticles
Poly(lactic-co-glycolic acid) (PLGA) nanoparticles with en-
trapped perfluoro-15-crown-5-ether (PFCE; for 19F MRI)
and indocyanine green (ICG; for fluorescence optical im-
aging) were prepared using an o/w emulsion and solvent
evaporation-extraction method as described previously
[35]. Briefly, 200 mg of PLGA (Resomer RG 502 H, lac-
tide/glycolide molar ratio 48:52 to 52:48; Boehringer Ingel-
heim, Germany) in 6 mL of dichloromethane, containing
1800 μL PFCE (Exfluor Inc., Round Rock, TX, USA) and
100 μL ICG-PULSION solution (10 mg/mL) (PULSION
Medical Inc., Feldkirchen, Germany) was added dropwise
to 50 ml of aqueous 0.4% polyvinyl alcohol and 1.6%
diethylaminoethyl-dextran and emulsified for 120 s using a
digital sonicator (Branson Ultrasonics, Danbury, CT, USA).
The solvent was evaporated and nanoparticles were col-
lected by centrifugation at 14.000 rpm for 20 min, washed
six times with distilled water and lyophilised. Dynamic light
scattering (DLS) was performed on a Malvern Zetasizer
Nano (Malvern Instruments Ltd., Malvern, United
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Kingdom). Sizes varied in the range of 210–360 nm and
zeta potentials were 6–27 mV. PFCE content was mea-
sured on a Bruker Avance III 400 MHz NMR (Bruker,
Rheinstetten, Germany). Nanoparticles contained 2.7–
6.0×1018 F atoms/mg dry weight.
Rat PI Isolation
We used pancreatic islets from Brown-Norway and Lewis
rats. Pancreatic islets were isolated according to a protocol
described by Gotoh [36]. Briefly, collagenase (1 mg/ml;
Sevapharma, Prague, Czech Republic) was injected intra-
ductally, after which the distended pancreas was excised
and gently shaken at 37 °C for 20 min. Islets were separated
from exocrine tissue using centrifugation in a discontinu-
ous Ficoll® gradient (Sigma-Aldrich, St. Louis, MO, USA).
Isolated islets were cultured for 24 h (37 °C, 5% CO2 at-
mosphere) in a CMRL-1066 medium (PANBiotech GmbH,
Aidenbach, Bavaria, Germany) supplemented with 10%
foetal bovine serum (FBS), 5% HEPES and 1% penicillin/
streptomycin/L-glutamine (all Sigma-Aldrich).
PI Labelling
Endocytosis
Endocytosis is a form of active transport used by cells to
internalise large polar molecules or solid particles, which
cannot pass through the hydrophobic plasma membrane.
In this energy-requiring process, used as a means of a
feeding, the cell engulfs the particle by forming a mem-
brane vesicle. First, plasma membrane creates a small in-
vagination where the particle is captured. Then, the
particle is fully surrounded forming a membrane vesicle
carrying the captured substance inside. Because of the
negative charge of the cell surface, positively charged
nanoparticles increase efficiency of the transfection [37].
Two hundred and fifty isolated PIs were incubated at
37 °C in a medium (84% CMRL-1066 medium, 10% FBS,
5% HEPES, 0.5% penicillin/streptomycin, and 0.5% gluta-
MAX (ThermoFisher Scientific, Waltham, MA, USA))
with suspended nanoparticles. The concentration of the
nanoparticles was 23 mg/mL medium. After 24-h incu-
bation, pancreatic islets were collected, washed three
times using phosphate buffer saline (PBS) and counted.
Microporation – Standard Procedure
Microporation – a modified electroporation method - is a
microbiology technique in which an electrical field is ap-
plied to cells in order to temporarily increase the perme-
ability of the cell membrane, allowing labels, drugs,
nucleic acids to be introduced into the cells. Micropora-
tion uses a pipette tip as an electroporation space and a
gold-coated electrode surface, therefore a uniform electric
field is produced with minimal heat production, metal ion
dissolution, or oxide formation, which may impair cells
during electroporation [38]. The standard protocol was
based on protocols provided by the manufacturer of the
device (see further) and tests performed by Lefebvre et al.
[33]; according to all published protocols, the electrical
pulses are applied in the presence of the substance of
interest in the transfection buffer (although number of
pulses, their voltage and length may differ).
The electroporation device Neon Transfection System
(ThermoFisher Scientific, Waltham, MA, USA) was used
for the experiment. Buffers from the original Neon™
Transfection System 100 μL Kit (ThermoFisher Scien-
tific, Waltham, MA, USA) were used. The Neon Tube
was filled by 3 mL of electrolytic Buffer E2 and the tube
was placed into the Neon Pipette Station. One hundred
and ten microliters samples containing 250 pancreatic
islets resuspended in the Buffer R with suspended nano-
particles (the final nanoparticle concentration was the
same at 23 mg/mL medium) were prepared. The islets
were aspired into a 100 μL pipette tip and placed in the
Neon Tube with the Electrolytic Buffer E2 according to
the manufacturer’s instructions. The islets were then
microporated using one, two, or four 20 ms pulses. The
pulse voltage varied in the range 600–1500 V (electric
field 20–50 kV/m). After microporation, the pipette was
immediately removed and the microporated islets were
placed in wells and kept on ice for 10 min. The islets
were then collected and placed in Petri dishes containing
3 mL of medium without antibiotics and incubated at
37 °C for 24 h. After incubation, pancreatic islets were
collected, washed three times using PBS, hand-picked
and counted under a microscope.
Microporation – Modified Protocol – “pre-Microporation”
Contrary to the standard protocol, the pancreatic islets
were porated without the nanoparticles. After this pre-
microporation, the islets were subsequently incubated
with the nanoparticles. This represents a fully new ap-
proach in terms of transfection of pancreatic islets.
The same device and chemicals were used as for the
standard procedure. The Neon Tube was filled by 3 mL of
electrolytic Buffer E2 and placed into the Neon Pipette Sta-
tion. Wells in a 96-well plate were filled by 110 μL of
medium with suspended nanoparticles (concentration
46 mg/mL). One hundred and ten microliters samples con-
taining 250 pancreatic islets in the pure Buffer R were pre-
pared. The islets were aspired into a 100 μL pipette tip and
placed in a tube with the Electrolytic Buffer E2 according to
the manufacturer’s instructions. The islets were then micro-
porated using two 20 ms pulses. The pulse voltage was
500–1000 V (electric field 16.5–33 kV/m). After micropora-
tion, the samples were immediately placed in wells contain-
ing 110 μL of the medium with suspended nanoparticles.
Final nanoparticle concentration after addition of the buffer
containing pre-microporated islets was 23 mg/mL. The is-
lets in the medium with nanoparticles were kept on ice for
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10 min. The islets were then collected and placed in Petri
dishes containing 3 mL of medium without antibiotics and
incubated at 37 °C for 24 h. After incubation, pancreatic is-
lets were collected, washed three times using PBS, hand-
picked and counted under a microscope.
A chart in Fig. 1 shows the basic difference between
the standard microporation procedure and the modified
protocol utilising pre-microporation.
Viability Test
After incubation, a viability test based on cell membrane
integrity detection stained with acridine orange and propi-
dium iodide [39] was performed. Acridine orange perme-
ates both live and dead cells and stains all nucleated cells
to generate a green fluorescence. Propidium iodide enters
dead cells with poor membrane integrity and generates a
red fluorescence. Cells stained with both dyes fluoresce
red due to quenching, i.e. all live nucleated cells fluoresce
green whereas all dead nucleated cells fluoresce red.
Ten islets in 20 μL of PBS were dropped into a 20 μL
staining solution containing acridine orange (75 μM)
and propidium iodide (9.4 μM) and then mixed. After
5 min of incubation, 250 μL of PBS was added and the
islets were then inspected under a fluorescence micro-
scope. Viability scores were determined according to the
percentage of cells stained green (live) and red (dead) for
each islet. The average percentage of viable cells was de-
termined for each sample.
Optical Fluorescence Imaging
Fluorescence images were acquired immediately after label-
ling on live islets in the medium placed in 0.5 mL test tubes
using an IVIS Lumina XR imager (Perkin Elmer, Waltham,
MA, USA) with the following parameters: exposure time
2 s, aperture four, excitation at 745 nm, emission filter at
810–875 nm. Regions of interest (ROI) of the same size
were drawn over each sample. The optical signal from the
ROI (average radiance) was expressed in arbritrary units
normalized to the signal of islets labelled by endocytosis.
Data were compared to the signal of PIs after endocytosis,
which was performed with each microporation experiment
(and was considered as a standard). Data could not be dir-
ectly compared between different experiments due to pos-
sible variations in geometry setting. A standard photograph
Fig. 1 A flowchart describing the steps of the standard microporation (left) and modified pre-microporation (right) procedures
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in the visible part of the light spectrum was acquired for
co-registration of the optical signal.
MR Imaging
After optical imaging, the pancreatic islets were fixed by
formaldehyde (4%, Sigma-Aldrich) and placed in 0.5 mL
test tubes prior to MR imaging. All MR measurements
were performed using a 4.7 T Bruker BioSpin imager (Bru-
ker, Rheinstetten, Germany) equipped with a homemade
1H/19F surface single-loop coil. The protocol consisted of
an 1H MRI pilot scan and an 1H T2-weighted turbo-spin
echo sequence (echo spacing TE = 12 ms, effective echo
time TEeff = 36 ms, repetition time TR = 3000 ms, turbofac-
tor 8, number of acquisitions NA = 4, field of view
FOV = 40 × 40 mm2, matrix 256 × 256). The coil was then
tuned to 19F nuclei, and the frequency and transmitter set-
ting was performed using a simple FID sequence. 19F MR
images were acquired using a turbospin echo sequence
(TE = 3.2 ms, TEeff = 42.2 ms, TR = 1000 ms, turbo factor
32, NA = 4096, FOV = 40 × 40 mm2, matrix 32 × 32 inter-
polated to 256 × 256 to match the 1H images). Fluorine im-
ages were coloured red and superimposed over the 1H
images in the gray scale by using ImageJ software [40].
Confocal Microscopy
Pellets of the pancreatic islets were fixed using formalde-
hyde (4%, Sigma-Aldrich) overnight. The islets were then
washed using PBS. Pellets were centrifuged (1 min at
1300 rpm), the supernatant was removed and agarose (2%,
Sigma-Aldrich) was added. Pellets in the agarose were im-
mediately centrifuged (1 min at 1800 rpm). After the agar-
ose solidified, the pellets were transferred into sucrose
(30%, Sigma-Aldrich) for overnight incubation at 4 °C.
After incubation, the islets were transferred to Tissue-Tek
(Sakura, Alphen aan den Rijn, Netherlands) and frozen in
methylbutane (Sigma-Aldrich, St. Louis, MO, USA)
cooled by liquid nitrogen. Frozen pellets were stored at
−80 °C. Sections (20 μm) from the pancreatic islet pellets
were cut using a cryomicrotome (Leica CM1950). The
samples were stained with diamino-phenylindole (DAPI,
Sigma-Aldrich, St. Louis, MO, USA) and mounted with a
vectashield (Vector H-1000, Burlingame, CA, USA) on a
glass slide. For confirmation of the nanoparticle signal and
its location, the Olympus FV1200MPE (Olympus life Sci-
ence, Tokyo, Japan) confocal microscope was used (green
background - Argon laser λ = 488 nm, DAPI - EPI lamp
λ = 405 nm, ICG - LD599 laser λ = 647 nm). The images
were taken using 20× (air) and 60× (oil immersion) objec-
tives under 200× or 600× magnification respectively.
Statistical Analysis
Values in the graphs are presented as averages, error
bars indicate standard deviations. Statistical tests were
used for comparing the viabilities and gains of the
differently treated samples containing pancreatic islets.
As the data sets were small and did not have normal dis-
tribution, a nonparametric Mann-Whitney U test was
employed. P < 0.05 was considered to indicate a statisti-
cally significant difference. Data from imaging methods
were usually obtained from a limited number of samples
(up to four), which did not allow meaningful usage of
the statistical tests, therefore, average values with stand-
ard deviations only are provided. Further repetitive mea-
surements were not performed due to ethical reasons;
pancreatic islets cannot be reproduced in vitro like cell
lines and each additional repetition would have required
another group of 20 animals for PI isolation.
Number of pulses was optimised at one voltage value
only, Mann-Whitney U test was used for comparison of
both viability and imaging.
All animal experimental protocols were approved by
the Ethics Committee of the Institute for Clinical and
Experimental Medicine and the Ministry of Health of
the Czech Republic in accordance with European Com-
munities Council Directive 86/609/EEC.
Results
Microporation According to the Standard Procedure
At first, we optimised number of pulses used for
microporation.
We compared viability, number of harvested islets (gain)
and labelling efficiency after one, two and four pulses (Fig.
2). The experiment revealed similar viability and gain in the
case of one and two pulses; both quantities significantly de-
creased when four pulses were used (Mann-Whitney U test,
P < 0.05), see Fig. 2a. Labelling efficiency was highest in the
case of two pulses (revealed by optical fluorescence imaging;
MRI provided significantly lower signal at one pulse and
similar signal at two and four pulses, see Fig. 2b). Therefore,
for further experiments, we used two pulses only.
The representative 19F MRI, optical and viability images
of PIs labelled using a standard microporation procedure,
modified one (only selected voltages are presented), and
endocytosis are shown in Fig. 3 including two control sam-
ples (unlabelled and unporated islets, and unlabelled islets
after poration without nanoparticles). Figure 3 confirmed
efficient labelling using the three labelling procedures, how-
ever, for proper comparison, MRI and optical signals, and
viability needed to be properly quantified. Figure 4 sum-
marised comparison of the standard protocol (Fig. 4a, c, e)
and the modified one (pre-microporation, Fig. 3b, d,) by
means of viability and gain of harvested islets (Fig. 4a, b),
19F MR signal (Fig. 4c, d), and fluorescent signal (Fig. 4e, f).
The percentage of harvested pancreatic islets 24 h after
microporation according to the standard protocol and via-
bility of harvested islets are shown in Fig. 4a, same data for
modified protocol (pre-microporation) in Fig. 4b. Viability
of the harvested islets was comparable for both methods.
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Viability of pancreatic islets microporated or pre-
microporated at a lower voltage (evaluated in harvested is-
lets 24 h after microporation) was similar to that of islets
simply incubated in the presence of the contrast agent
(endocytosis). A higher voltage (900–1500 V) in the case of
the standard protocol significantly decreased viability of la-
belled and harvested islets compared to islets labelled by
endocytosis (U test, P < 0.05, marked by “*” in Fig. 4a).
Similarly, viability decreased gradually with increasing volt-
age in the case of the modified protocol; at 800 V and
higher the decrease was significant compared to endocyto-
sis (P < 0.5, marked by “*” in Fig. 4b).
Percentages of harvested islets after microporation (gain,
100% = number of islets before labelling) were significantly
lower in the case of standard procedure compared to endo-
cytosis even at low voltage applied during microporation
(U test, P < 0.05, marked by “×” in Fig. 4a). Contrary to this,
gain in the case pre-microporation was comparable to
endocytosis at lower voltages. Significant decrease of the
gain was observed at pre-microporation using 1000 V only
(U test, P < 0.5, marked by “×” in Fig. 4b).
Both MRI and optical fluorescence imaging proved
that collected PIs were efficiently labelled by both micro-
poration procedures (Fig. 4c-f).
Based on 19F MR data analysis, the labelling efficiency of
microporation using the modified protocol was substan-
tially lower than endocytosis (Fig. 4d). However, a 1-h MR
scan still provided a detectable signal from 250 micropo-
rated islets.
In contrast, for optical fluorescence imaging (Fig. 4f) the
endocytosis provided the lowest signal, albeit not signifi-
cantly different from the signal of pre-microporated islets
due to high data dispersion. High probe content (proved
by 19F MRI, Fig. 4d) in the case of islets after endocytosis
did not lead to correspondingly high optical signal. This
discrepancy can be explained by quenching of the optical
signal caused by locally high concentration of the probe in
the islets. The phenomenon of a decrease of a normalized
fluorescent signal with increasing ICG concentration was
described by Yuan et al. [41]. Two effects may be respon-
sible for this decrease. Propagation depth of the excitation
light in the solution decreases with the increasing ICG
concentration. It consequently causes decreasing illumin-
ation by the excitation light, and therefore the decay of
the emission strength. With increasing concentration in-
creases also re-absorption of emission photons, which
contributes to the decay of the emission strength too.
To confirm this, we tested the fluorescence of the
probe itself in vitro. Figure 5 shows a decrease in fluor-
escent signal intensity at higher concentrations caused
by signal quenching, which corresponds to the curve
shapes in [41]. MRI signal increased linearly with in-
creasing concentrations. Both optical and MRI images of
the test tubes with different nanoparticle concentrations
are shown under the graph.
Confocal microscopy of the fixed pancreatic islets con-
firmed the presence of fluorescent nanoparticles in islets la-
belled using microporation or endocytosis (see Fig. 6).
Higher fluorescent signals (red) in the case of endocytosis
showed higher efficiency of labelling by endocytosis com-
pared to microporation, a finding which is in agreement
with MR results.
Our results indicated that standard microporation proto-
col led to substantial loss of islets during the procedure.
Fig. 2 Comparison of viability, gain (a) and fluorescent and MRI signals (b) at various pulse numbers. Viability and gain were comparable at one
and two pulses and significantly lower at four pulses (Mann-Whitney U test, P < 0.05, marked by “*”). Labelling efficiency was highest using two
pulses; fluorescent signal was significantly higher than the signal of samples porated using one or four pulses (marked by “*”). MRI signal was
significantly higher compared to the case of one pulse (marked by “+”) and comparable to the sample porated using four pulses
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Also, higher voltage pulses (>800 V) as well as usage of
more than two pulses led to radical impairment of islet via-
bility (Figs. 2a and 3a, b).
Therefore we fixed the optimal settings for pancreatic
islet labelling using microporation as follows:
 “pre-microporation”: microporation without
nanoparticles with two 20 ms pulses 600 V (field
20 kV/m),
 placing of microporated islets in the medium with
suspended nanoparticles (final concentration 23 mg/
mL value in the solution) on ice for 10 min,
 transferring islets to a Petri dish containing the
medium and 24-h incubation at 37 °C for recovery
(incubation may be shorten, if necessary).
This protocol ensures the high gain and viability of the
islets as well as reasonably high labelling efficiency.
It should be noted that the protocol was optimized for
the nanoparticles used in this study, which have an aver-
age diameter of 200 nm and a slight positive charge.
Microporation efficiency may substantially differ with
different contrast agents.
Discussion
Pancreatic islet transplantation represents an alternative
treatment for Type 1 diabetes, however, in vivo monitor-
ing of the transplant is still a challenge. It requires label-
ling of islets corresponding to the used imaging method.
19F MRI is a highly specific method, albeit with low sen-
sitivity, which is therefore scarcely used [42]. Combin-
ation with a more sensitive fluorescent probe seems to
be a suitable solution. To ensure sufficient probe con-
tent and viability of the islets, labelling strategies should
be carefully optimised with respect to the selected probe
and complex islet structure.
Fig. 3 Images of pancreatic islets labelled with fluorine nanoparticles using microporation according to the standard protocol (a), endocytosis (b),
pre-microporation (c), and unlabelled controls (d). 19F (red) MR images superimposed on 1H (grey scale) MR images (upper row), fluorescence
images (middle) and selected microphotographs of islets stained for the viability test. Selected voltages (600, 800, 1000 V) used for microporation
or pre-poration are shown. Unporated control represents unlabelled islets incubated without any intervention in the pure medium. Porated
control contains islets porated in the buffer only (600 V) and incubated without nanoparticles
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Fig. 4 Viability and gain of pancreatic islets (a, b), MR signal (c, d) and fluorescent signal (e, f) from optical fluorescence imaging of phantoms
containing PIs labelled by microporation using the standard procedure (left: a, c, e) and modified protocol (right: b, d, f). MR signal (c, d) was expressed
as a contrast-to-noise ratio, fluorescent signal intensity is in arbitrary units proportional to average radiance. Significant decrease of viability (P < 0.05,
marked by “*”) compared to endocytosis was observed at voltage 900 V and higher in the case of the standard protocol (a) and 800 V and higher in
the case of modified protocol (b). Gain was substantially lower (P < 0.05, marked by “×”) in the case of the standard protocol at any voltage setting (a);
whereas in the case of the modified protocol (b), significant gain decrease was observed at 1000 V only (P < 0.05, marked by “×”)
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Although electroporation is widely used for cell label-
ling, there are only a few reports on pancreatic islet label-
ling. Tai et al. [32] successfully used electroporation at
lower voltages (up to 100 V) for SPIO-based labels. How-
ever, in our experience, microporation (which requires a
higher voltage due to electrode geometry) is an invasive
procedure and may cause cell death using any combin-
ation of parameters. In our study, the number of islets de-
creased substantially after microporation, especially at
higher voltages. Moreover, viability was tested on un-
broken islets and does not reflect the fact that some islets
were completely destroyed or lost during labelling. Also, it
should be noted that the procedure itself demands skilful
work, since pancreatic islets require 100 μL pipette tips
(which are broader) and the islets tend to fall out of the
tips quite quickly due to gravity when the pipette is posi-
tioned vertically during microporation.
Microporation according to the standard procedure
(i.e. in the presence of nanoparticles) was very difficult.
The coloured suspension made visual control of the is-
lets impossible during microporation and parts of the
pancreatic islets may have been lost in the electrolytic
buffer during the procedure. In addition, the nanoparti-
cle suspension was somewhat foamy and air bubbles
caused occasional arcing (sparks) in the sample, which
harmed the islets. The bubbles are in fact caused by the
Fig. 5 Dependence of the fluorescent signal (full circles, solid line)
and of the 19F MRI signal (empty squares, dotted line) from the
nanoparticle suspension on concentration. The fluorescent signal
decreased at high probe concentrations due to signal quenching,
while the MRI signal linearly increased. Actual fluorescent and MRI
images of the test tubes with nanoparticles at different
concentrations are presented below the graph
Fig. 6 Confocal microscopy of the fixed sliced pancreatic islet samples. Upper row – a control sample of unlabelled pancreatic islets; middle row –
islets labelled by microporation according to the modified protocol at 600 V; lower row – islets labelled by endocytosis. Artificial colours represent
autoluminescence (green), DAPI (blue) and the fluorescent signal of ICG bound to nanoparticles (red). The far right column shows an overlap of
green, blue and red signals. The scale bar represents 50 μm
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nanoparticles used. At a certain concentration the sus-
pension becomes foamy due to the hydrophilic surface
of the polymer [35]. The nanoparticles probably decrease
surface tension and behave like a surfactant. Although
visible bubbles were removed before microporation, the
removal of microbubbles responsible for sparks during
poration is virtually impossible.
The original microporation procedure (voltage applica-
tion in the presence of nanoparticles) often led to sparks
in the solution with islets, resulting in their destruction.
The modified protocol (microporation without the nano-
particles and placing the porated islets in the medium
with nanoparticles immediately after voltage application)
avoided these problems. Incubation of the islets on ice
after microporation slowed down the sealing of the
membranes and enabled nanoparticle uptake. The out-
comes from the labelling according to the modified
protocol were more than 2-fold higher.
Comparing Microporation and Endocytosis
In contrast to microporation, the uptake of the agent by
endocytosis was simple, efficient, and did not substan-
tially affect cell viability. Microporation according to the
standard protocol may label islets at comparable effi-
ciency, but islet viability is compromised and many islets
may be lost during the procedure. Microporation ac-
cording to the modified protocol ensures higher viability
and lower loss of islets. The only comparable setting for
microporation in terms of viability was the usage of two
low voltage pulses 600 V/20 ms (without nanoparticles
– i.e., “pre-microporation”) and incubation in the pres-
ence of nanoparticles on ice for 10 min. Brief exposure
to nanoparticles might be beneficial in specific applica-
tions and the method may be suitable when fast labelling
is required. Although labelling under these conditions
was not as efficient as 24-h labelling using simple endo-
cytosis being up to 3-fold lower, it is necessary to keep
in mind that faster labelling procedures may fit better in
clinical or preclinical schedules. 10 min incubation on
ice adjusted according to [35] represents a reasonable
time interval for sufficient islet labelling and still with no
adverse effects on islet viability.
The discrepancy between semi-quantitative evaluation
of MR images and optical signals (Fig. 4d and f) also in-
dicates that high labelling efficiency is not necessarily
better for optical fluorescence imaging. High label con-
centrations lead to signal losses due to quenching. High
uptake of the probe by endocytosis (confirmed in our
experiment by MRI, Fig. 4d, and confocal microscopy,
Fig. 6) thus resulted in a similar optical signal (Fig. 4f ).
We observed signal quenching at higher concentrations
in the pure nanoparticle suspension (Fig. 5) manifested
by fluorescent signal decrease, while MRI signal in-
creased with increasing concentration. We presume that
the average concentration in the medium with labelled
PIs was lower. However, the nanoparticles may not have
been evenly distributed within the PI pellets, which may
have led to signal loss.
Although optical imaging is often presented as a quantita-
tive method, signal quenching makes exact quantitation of
the source particles impossible. Nevertheless, it should be
noted that under in vivo conditions, islets may be more dis-
persed than under in vitro conditions, and the effect of
quenching may be negligible. Also, quantitation of MR sig-
nals from images may be subject to errors and artefacts
when taking into account the following hardware and soft-
ware limitations: use of a surface coil with substantial B1 in-
homogeneity, low measurement matrix (32 × 32), filtering
during post-processing, and Fourier transform, leading to
partial signal (and noise) dispersion across the whole image
matrix.
Conclusions
The experiment confirms that microporation – although
a fast and effective labelling method and one that is doc-
umented in the literature as a treatment for use with PIs
– is invasive and may cause substantial harm to islets.
We modified the protocol and optimised microporation
parameters to achieve sufficient labelling and minimise
viability loss during the procedure. Poration in the pres-
ence of nanoparticles was found to be unsuitable for the
PLGA nanoparticles used and therefore was replaced by
pre-microporation of islets in the buffer without nanopar-
ticles. Moving the islets into the nanoparticle suspension
after poration and keeping them on ice for 10 min slowed
down the sealing of pores and facilitated the migration of
nanoparticles to cells. Subsequent incubation in the
medium at 37 °C enabled the pores to be sealed and the
recovery of islets.
Compared to endocytosis, the labelling efficiency of
microporation was lower despite the modified protocol sub-
stantially improving the viability and gain of the method.
However, the labelling with pre-poration was very fast.
Microporation may thus be considered a suitable la-
belling procedure when fast cell labelling is desired.
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